MA life sciences jobs growth program soars; Abbott revs up for Q1 2013 earnings discussion;

 @FierceMedDev: Dx approach offers chance to spot pancreatic cancer earlier. Story | Follow @FierceMedDev

 @MarkHFierce: Sony and Olympus have delayed their joint medical device venture again. Talk about unrealized potential. More | Follow @MarkHFierce

 @DamianFierce: A Chinese court is asking the SFDA to crack down on local clinical trial regulations. Article | Follow @DamianFierce

> Massachusetts' 10-year, $1 billion life sciences investment plan created 2,500 jobs during its first four years, a new study from Northwestern University concludes. Story

> Eye diagnostics company MacuLogix, which just closed on a $3.6 million Series A round, is now actively raising $5 million in Series B financing. Story (sub. req.)

> Abbott ($ABT) plans to disclose its 2013 first quarter earnings on Wed. April 17, 2013--its first since spinning off its brand-name drug business into its own company called AbbVie ($ABBV). Abbott now focuses on medical devices, diagnostics, nutritional products and generic drugs. Item

> A team of European researchers from various institutions developed a half-inch implant designed to track sugar and enzyme levels in the blood. It transmits data wirelessly to a patient's smartphone. Story

> A U.K. review of the breast implant industry in the wake of a scandal over faulty French implants will be released later in April. Item

> BioElectronics secured a new U.S. patent for a device designed to reduce both pain and inflammation. Item

> Vascular Solutions ($VASC) CEO Howard Root made $3.13 million in 2012. That's 237% higher than the previous year, due to a big boost in stock and option awards. Item

Biotech News

 @FierceBiotech: Sanofi to build $75m plant in Vietnam. Market there growing fast, and so is payer coverage. Article | Follow @FierceBiotech

@JohnCFierce: While India's SC strikes at pharma, the U.K. tees up a sweet tax deal for patented pharma products--the "patent box." More | Follow @JohnCFierce

@RyanMFierce: Amgen claimed Big Data software prize in $415M deCODE buyout. Report | Follow @RyanMFierce

> New math on biosimilars sends a chilling message to Lonza/Teva team. More

> Clashing stands of India, U.K. on drug patents, R&D will offer clear lessons. Article

> J&J wins first FDA approval for new class of diabetes drug. News

Pharma News

@FiercePharma: Reports of serious reactions to Affymax's Omontys surfaced last August, WSJ says, 6 months b/f recall. More | Follow @FiercePharma

@EricPFierce: Pfizer's Xeljanzi forecast to hit $1.86 billion by 2016 but Amarin's Vascepa disappoints. Story | Follow @EricPFierce

> J&J faces big spending, big rivals for new diabetes drug Invokana. Report

> Sanofi plots new production in China, Vietnam to fuel Asian growth. More

> Biogen prices Tecfidera below oral MS rival Gilenya. Article

CRO News

> Biotrial takes tech, talent from failing Forenap. Story

> ReSearch launches joint venture with Japanese CRO. News

> bioRASI buys Ukraine CRO for E. Europe heft. Article

> Frontage gets FDA chiding over Chinese lab. Item

> Chinese court wants tougher clinical trial regs. Report

Biotech IT News

> George Church-affiliated startup blueprints genetic data marketplace. News

> FoldIt creator wins Bill Gates nod for science crowdfunding site. Item

> Sequoia-backed genomics startup, others face who-pays hurdle. Story

> NSF touts role of supercomputer in autism, neuroscience discoveries. Article

> Big Data sheds light on pharma's 'Small Data' problems. Industry Voices

> 5 keys to going mobile in pharma. Editor's Corner

Suggested Articles

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.